Search results
Afinitor interactions: Other medications, alcohol, and more
Medical News Today· 1 day agoAfinitor has interactions with some other drugs and certain supplements. Before you start treatment...
Cameron Mathison Shares Heartfelt Post as His Daughter Leila Heads to Prom: ‘Always on My Mind and...
People Magazine· 6 days agoCameron Mathison shared a tender moment with his daughter Leila as she prepared to head off to her...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 2 days agoModerna detailed plans for its individual neoantigen cancer vaccine in a first-quarter earnings...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 2 days agoModerna/Merck also started two separate mid-stage studies in renal cell carcinoma and...
Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short
Zacks via Yahoo Finance· 3 days agoCabometyx (cabozantinib) generated revenues of $376.4 million, which missed the Zacks Consensus...
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Receives $24.64 Average Target Price from Analysts
ETF DAILY NEWS· 5 days agoShares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) have been given a consensus rating of “Buy” by the ten ratings firms that are currently covering the stock, Marketbeat ...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Exelixis (NASDAQ:EXEL) Earns “Outperform” Rating from William Blair
ETF DAILY NEWS· 13 hours agoWilliam Blair reaffirmed their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Wednesday, RTT News reports. Barclays lowered Exelixis from an overweight ...
Sutent Dosage: Form, Strengths, How to Take, and More
Healthline· 3 days agoSutent is a prescription drug used to treat certain types of cancer. Learn about the drug's dosages, form, strengths, how to take it, and more.
New York State Common Retirement Fund Sells 5,141 Shares of Iovance Biotherapeutics, Inc....
ETF DAILY NEWS· 2 days agoNew York State Common Retirement Fund trimmed its holdings in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 0.5% during the 4th quarter, according to the company in ...